Naphazoline Hydrochloride and Pheniramine Maleate (Akorn, Inc.)
Welcome to the PulseAid listing for the Naphazoline Hydrochloride and Pheniramine Maleate drug offered from Akorn, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Akorn, Inc. |
NON-PROPRIETARY NAME: | Naphazoline Hydrochloride and Pheniramine Maleate |
SUBSTANCE NAME: | NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | OPHTHALMIC |
DOSAGE FORM: | SOLUTION/ DROPS |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2013-01-24 |
END MARKETING DATE: | 0000-00-00 |
Naphazoline Hydrochloride and Pheniramine Maleate HUMAN OTC DRUG Details:
Item Description | Naphazoline Hydrochloride and Pheniramine Maleate from Akorn, Inc. |
LABELER NAME: | Akorn, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | .25; 3(mg/mL; mg/mL) |
START MARKETING DATE: | 2013-01-24 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 17478-065_c9952204-fb64-42f5-8bb5-c18f325e0f30 |
PRODUCT NDC: | 17478-065 |
APPLICATION NUMBER: | ANDA202795 |
Other NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE Pharmaceutical Manufacturers / Labelers: